Results 61 to 70 of about 2,048,259 (212)

A Rare Case of Myelodysplastic Syndrome with Ring Sideroblasts, SF3B1 and TET2 Mutations in a Patient with Beta Thalassemia Trait [PDF]

, 2017
Concurrent myelodysplastic syndrome (MDS) and β-thalassemia trait is rare. We reported a case of a 59-year-old man with a known history of β-thalassemia (presumed to be β-thalassemia intermedia) presenting with progressive anemia and worsening fatigue. β-
Fang, Yanan, Wang, Yanhua, Ahlstedt, Jeffrey   +2 more
core   +2 more sources

An International MDS/MPN Working Group’s perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms

Haematologica, 2015
In the 2008 WHO classification, chronic myeloid malignancies that share both myelodysplastic and myeloproliferative features define the myelodysplastic/myeloproliferative group, which includes chronic myelomonocytic leukemia, juvenile myelomonocytic ...
Tariq I. Mughal, Nicholas C.P. Cross, Eric Padron, Ramon V. Tiu, Michael Savona, Luca Malcovati, Raoul Tibes, Rami S. Komrokji, Jean-Jacques Kiladjian, Guillermo Garcia-Manero, Attilio Orazi, Ruben Mesa, Jaroslaw P. Maciejewski, Pierre Fenaux, Raphael Itzykson, Ghulam Mufti, Eric Solary, Alan F. List   +17 more
doaj   +1 more source

Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases

Mediterranean Journal of Hematology and Infectious Diseases, 2022
Sideroblastic anemia (SA) is a rare heterogenous group of inherited and acquired bone marrow disorders. We retrospectively studied the clinicopathologic characteristics, cytogenetic findings, and disease outcome of patients with acquired sideroblastic ...
Dina Sameh Soliman, Samah Kohla, Shehab Fareed, Susanna Akiki , Aliaa Amer, Ibrahim Ganwo, Prem Chandra, Halima El-Omri, Feryal Ibrahim   +8 more
doaj   +1 more source

Prognostic impact of SF3B1 mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases

Haematologica
The revised 4th edition of the World Health Organization (WHO4R) classification lists myelodysplastic syndromes with ring sideroblasts (MDS-RS) as a separate entity with single lineage (MDS-RS-SLD) or multilineage (MDS-RS-MLD) dysplasia.
F. Farrukh, Maymona G. Abdelmagid, Abhishek Mangaonkar, Mrinal S. Patnaik, A. Al-Kali, M. Elliott, K. Begna, C. C. Hook, William J. Hogan, A. Pardanani, M. Litzow, R. Ketterling, N. Gangat, D. Arber, A. Orazi, R. He, K. Reichard, A. Tefferi   +17 more
semanticscholar   +1 more source

Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN‐RS‐T) and myelodysplastic syndrome with ring sideroblasts (MDS‐RS)

American journal of hematology/oncology, 2021
REFERENCES 1. Kumar SK, Callander NS, Hillengass J, et al. NCCN guidelines insights: multiple myeloma, version 1.2020. J Natl Compr Canc Netw. 2019;17 (10):1154-1165. 2. Cheson BD, Leoni L. Bendamustine: mechanism of action and clinical data.
G. Montalban-Bravo, R. Kanagal-Shamanna, F. Darbaniyan, M. Siddiqui, K. Sasaki, Yue Wei, Hui Yang, K. Chien, K. Naqvi, E. Jabbour, T. Kadia, N. Daver, C. Dinardo, F. Ravandi, N. Pemmaraju, P. Bose, S. Verstovsek, S. Pierce, C. Bueso-Ramos, K. Patel, K. Do, H. Kantarjian, G. Garcia-Manero   +22 more
semanticscholar   +1 more source

Refractory Anemia With Ring Sideroblasts Associated With Marked Thrombocytosis

, 2011
Refractory anemia with ring sideroblasts associated with marked thrombocytosis (RARS-T) is a provisional entity in the current World Health Organization classification and is thought to be a myelodysplastic/myeloproliferative neoplasm (MDS/MPN).
C. Cameron Yin, Pei Lin, Inga Gurevich, L. Jeffrey Medeiros, Raja Luthra, Sergej N. Konoplev   +5 more
core   +1 more source

PIMREG (PICALM interacting mitotic regulator) [PDF]

, 2017
Review on Myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and ...
Frôhlich Archangelo, Leticia, Ohgami, Robert S   +1 more
core   +1 more source

Linezolid-induced ringed sideroblastic anemia and thrombocytopenia in a child with extensively drug-resistant tuberculosis

Indian Pediatrics Case Reports, 2021
Background: With the ever-evolving guidelines and changing drug regimens for pediatric tuberculosis (TB), it is paramount for treating physicians to understand the efficacy and safety profiles of the drugs being used.
Snigdha Sippy, Amit Nisal, Bhakti U Sarangi   +2 more
doaj   +1 more source

ICSH Guidance on Bone Marrow Examination and Reporting

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Examination of the bone marrow (BM) remains fundamental to the diagnosis, classification, prognostication, and monitoring of hematolymphoid and other disorders affecting blood cell production. Since publication of the International Council for Standardization in Haematology (ICSH) guideline in 2008, advances in diagnostic technologies, disease
Wendy N. Erber, Alexandar Tzankov, Olga Pozdnyakova, Hiromichi Matsushita, Gina Zini, Leonie Saft, on behalf of the International Council for Standardization in Haematology   +6 more
wiley   +1 more source

Luspatercept in Myelodysplastic Syndrome: A Review of Efficacy and Safety Data

Безопасность и риск фармакотерапии
INTRODUCTION. Transfusion-dependent anemia in myelodysplastic syndrome (MDS) is associated with severe complications and reduced survival, with up to 70% of patients being refractory to standard therapy with erythropoiesis-stimulating agents (ESAs).
O. S. Levchenkova, V. E. Novikov, V. V. Vorobieva, L. P. Zharkova   +3 more
doaj   +1 more source